Healthcare -
Biotechnology - NASDAQ - US
$ 103.32
-3.21 %
$ 9.87 B
Market Cap
44.15
P/E
SRPT - COST OF REVENUE
Cost of Revenue SRPT - Sarepta Therapeutics, Inc.
150 M
LAST VALUE
24.46%
2 YEAR CAGR
34.47%
5 YEAR CAGR
5.23%
10 YEAR CAGR